Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: InDi Hires Bencich and Tonachio

Premium

Integrated Diagnostics has appointed John Bencich as chief financial officer and Jill Tonachio as vice president for sales.

Bencich most recently served as the CFO of Allozyne. Prior to that, he was vice president, chief financial officer, and treasurer of Trubion Pharmaceuticals until its acquisition by Emergent BioSolutions. Before that he was the director of finance and corporate controller for Onyx Software. He holds a BA in accountancy from the University of San Diego and an MBA from Seattle University.

Tonachio was most recently national director of sales for Aurora Diagnostics. She has also held sales positions at Aureon Laboratories, Laboratory Corporation of America, Dianon Systems, and Johnson & Johnson. She holds a BS in business logistics from Pennsylvania State University.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.